Common Contracts
2 similar Grant Agreement contracts
GRANT AGREEMENTGrant Agreement • April 18th, 2024
This Grant Agreement (“Agreement”) is entered into as of August 30th 2023 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Hudsagen (CVR no. 81935319) in collaboration with Advice A/S (CVR no. 20212209), an organization and a company, respectively, incorporated under the laws of Denmark, located at Blekinge Boulevard 2, DK-2630 Taastrup and Gammel Kongevej 3E, DK-1610 Copenhagen V (collectively referred to as “Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
GRANT AGREEMENTGrant Agreement • September 16th, 2023
This Grant Agreement (“Agreement”) is entered into as of August 30th 2023 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Hudsagen (CVR no. 81935319) in collaboration with Advice A/S (CVR no. 20212209), an organization and a company, respectively, incorporated under the laws of Denmark, located at Blekinge Boulevard 2, DK-2630 Taastrup and Gammel Kongevej 3E, DK-1610 Copenhagen V (collectively referred to as “Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
